A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 Given for Multiple Days and to Test How NDI-5001 is Tolerated and Taken up in the Body

NCT07525960 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

X-linked Congenital Nephrogenic Diabetes Insipidus

Interventions

DRUG: NDI-5001

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.